Table I.

Demographic and clinical characteristics of the reviewed cohort

Authors	Ref	Patient	Gender		Age (years)	Smoking history (Y/N)	Tumour site	Tumour size (cm)	Lymphnode metastasis (Y/N)	Site of distant metastasis	cTNM staging1	Treatment	Follow up/Months
Yoshida K, Fujiwara Y, et al.	23	1		F	33	N	Left pleura	Multiple tumours	N	None	cTxN0M0	Adjuvant CT	DOD/10
Haberecker M, Buhler MM, et al.	24	2		F	20	N	Anterior mediastinum	~4	N	Bone, lung3, soft tissue and nerve plexus	cTxN0M1c	Adjuvant CT	DOD/16
		3		M	25	Y	Pleura/thoracic wall, axilla	15,8	Y	Pleura	cT4N2M1a	Adjuvant CT	DOD/17
		4		M	51	Y	Lung, central/hilar	4-5	Y	Pleura	cT2bN2M1a	Adjuvant CT	DOD/6
		5		M	56	Y	Pleura	-2	N	None	cTxN0M0	Adjuvant CT	DOD/1
		6		M	76	NA	Lung, subpleural	3,5	N	NA	cT2aN0M0	NA	NA/2
		7		M	73	Y	Lung, central/hilar	5	Y	Liver, adrenal gland	cT2bN2M1c	Neoadjuvant and adjuvant CT	DOD/7
		8		M	64	Y	Pleura	-2	N	None	cT3N0M0	Adjuvant CT	DOD/10
		9		M	72	Y	Lung, central/hilar	9	N	Lung3	cT4N0M1a	Adjuvant CT	DOD/53
		10		M	77	N	Posterior mediastinum/esophagus	10	N	None	cT4N0M0	Neoadjuvant CT	DOD/4
Zhou YH, Qin S, et al.	25	11		M	74	NA	Lung, RUL	3,5	N	None	cT2NcMx	Neoadjuvant RT	DOD/5+4
Rickard JA, Burr M, et al.	26	12		M	60s5	N	Lung, LLL	8,6	Y	Liver	cT4N2M1c	Neoadjuvant CT	AWD
Chen J, Wang J	27	13		M	61	N	Lung, LUL	8,8	Y	None	cT4N2M0	Neoadjuvant and adjuvant CT	NED/4+6
Present case	-	14		M	38	N	Lung, RML	5,8	N	None	cT3N0M0	Neoadjuvant CT	DOD/11
1 according to the available data, 2 entire lateral parietal pleura, 3 data regarding precise location not available, 4 patient was alive with disease after 5 months of radiotherapic treatment and died of disease after therapeutic failure (interval is not reported in the original article), 5 in the original article, the authors report that the patient is in his sixties with no further clarification, 6 in the original article, no further clarification is given on the follow-up time
AWD alive with disease, CT chemotherapy treatment, DOD died of disease, IHC immunohistochemistry, LLL left lower lobe, LUL left upper lobe, NA not available, NED no evidence of disease, RML right middle lobe, RUL right upper lobe